Cargando…
Omicron-specific mRNA vaccination alone and as a heterologous booster against SARS-CoV-2
The Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has high transmissibility and recently swept the globe. Due to the extensive number of mutations, this variant has high level of immune evasion, which drastically reduced the efficacy of existing antibodies and vacci...
Autores principales: | Fang, Zhenhao, Peng, Lei, Filler, Renata, Suzuki, Kazushi, McNamara, Andrew, Lin, Qianqian, Renauer, Paul A., Yang, Luojia, Menasche, Bridget, Sanchez, Angie, Ren, Ping, Xiong, Qiancheng, Strine, Madison, Clark, Paul, Lin, Chenxiang, Ko, Albert I., Grubaugh, Nathan D., Wilen, Craig B., Chen, Sidi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863141/ https://www.ncbi.nlm.nih.gov/pubmed/35194606 http://dx.doi.org/10.1101/2022.02.14.480449 |
Ejemplares similares
-
Omicron-specific mRNA vaccination alone and as a heterologous booster against SARS-CoV-2
por: Fang, Zhenhao, et al.
Publicado: (2022) -
Variant-specific vaccination induces systems immune responses and potent in vivo protection against SARS-CoV-2
por: Peng, Lei, et al.
Publicado: (2022) -
Heterotypic vaccination responses against SARS-CoV-2 Omicron BA.2
por: Fang, Zhenhao, et al.
Publicado: (2022) -
Multiplexed LNP-mRNA vaccination against pathogenic coronavirus species
por: Peng, Lei, et al.
Publicado: (2022) -
Bivalent mRNA vaccine booster induces robust antibody immunity against Omicron lineages BA.2, BA.2.12.1, BA.2.75 and BA.5
por: Fang, Zhenhao, et al.
Publicado: (2022)